Literature DB >> 15463894

Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosis.

N Dauletbaev1, K Viel, R Buhl, T O F Wagner, J Bargon.   

Abstract

BACKGROUND: Reduced glutathione (GSH) is a major antioxidant in the lung. In cystic fibrosis (CF) patients, extracellular GSH levels of lower airways, obtained by bronchoalveolar lavage (BAL), were reported to be lower than non-CF individuals.
METHODS: Upper airway secretions of stable adult CF patients (29 spontaneous and 13 induced sputum) and non-CF individuals (14 healthy and 12 asthmatics; all induced sputum) were analyzed for total glutathione (i.e. the sum of reduced, GSH, and oxidized, GSSG, forms), GSH and GSSG levels by enzymatic kinetic assay.
RESULTS: In CF, both spontaneous and induced sputum samples were comparable in total glutathione levels which were surprisingly high (median concentration of 9.2 (range 1.4-65.2) and 11.6 (1.1-69.8) microM, respectively). In non-CF individuals, total glutathione levels were significantly lower (healthy 2.8 (1.0-12.3), asthmatics (5.3 (1.3-19.2) microM; p<0.001, both vs. CF). In CF, more than 90% of total glutathione was represented by GSH, whereas in non-CF controls, GSH made up less than 50% of total glutathione (p<0.001).
CONCLUSIONS: In contrast to BAL, CF sputum contains high levels of GSH. Sputum induction is a potentially useful procedure to monitor antioxidant levels in upper airways of CF patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15463894     DOI: 10.1016/j.jcf.2004.03.005

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  9 in total

1.  Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid.

Authors:  K Nagai; T Betsuyaku; T Kondo; Y Nasuhara; M Nishimura
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

2.  Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms.

Authors:  Nurlan Dauletbaev; Daniel Eklove; Nadir Mawji; Michele Iskandar; Sergio Di Marco; Imed-Eddine Gallouzi; Larry C Lands
Journal:  J Biol Chem       Date:  2011-03-15       Impact factor: 5.157

3.  Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis.

Authors:  Charles R Esther; Lidija Turkovic; Tim Rosenow; Marianne S Muhlebach; Richard C Boucher; Sarath Ranganathan; Stephen M Stick
Journal:  Eur Respir J       Date:  2016-11-11       Impact factor: 16.671

4.  A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration.

Authors:  Chirag Kariya; Heather Leitner; Elysia Min; Christiaan van Heeckeren; Anna van Heeckeren; Brian J Day
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-03-16       Impact factor: 5.464

5.  Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice.

Authors:  Emily M Bradford; Maureen A Sartor; Lara R Gawenis; Lane L Clarke; Gary E Shull
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-22       Impact factor: 4.052

6.  A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis.

Authors:  N Dauletbaev; P Fischer; B Aulbach; J Gross; W Kusche; U Thyroff-Friesinger; T O F Wagner; J Bargon
Journal:  Eur J Med Res       Date:  2009-08-12       Impact factor: 2.175

Review 7.  High-Dose Ibuprofen in Cystic Fibrosis.

Authors:  Larry C Lands; Nurlan Dauletbaev
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-13

Review 8.  Oxidative Stress Markers in Sputum.

Authors:  Balazs Antus
Journal:  Oxid Med Cell Longev       Date:  2016-01-14       Impact factor: 6.543

9.  Low concentrations of clarithromycin upregulate cellular antioxidant enzymes and phosphorylation of extracellular signal-regulated kinase in human small airway epithelial cells.

Authors:  Kuninori Iwayama; Junpei Kimura; Aya Mishima; Ayuko Kusakabe; Ko-Ichi Ohtaki; Yoshiko Tampo; Nobumasa Hayase
Journal:  J Pharm Health Care Sci       Date:  2018-09-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.